Eli Lilly's U.S. revenues grew by 39% to 6,188.1 million euros, with international revenues up 10% to 2.7 billion euros. R&D costs rose by 29.5%, while...
Within the health sector, 20% of investment in R&D came from the ten largest companies by investment, which allocated €53.9 billion, €10 billion more than the...
Looking at application sectors, although the activity of biotech companies in Italy remains largely concentrated in human health (just under 50 percent), between 2014 and 2021...
Spanish biotech companies maintain their leading position in the industrial sector in science with the highest percentage of researchers. The research workplaces Spain in the ninth position...
Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...
Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
Within the pharmaceutical investment in research and development it is necessary to distinguish between different parts of the process. Almost $78 million (€66 million) were allocated...
The biotech sector in Spain is committed to investments in R&D, as the latest report by Asebio showed. More than 70% of the total investments in...
Spain become one of the countries with the best conditions to host the research and development of new medicine. To the point that Spanish doctors and...